We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.
HomeHormone TherapyBioidentical HRTNew York
Mid-Atlantic · Telehealth Available

Bioidentical Hormone Therapy in New York — Online

Bioidentical hormone therapy uses hormones that are molecularly identical to those produced by the body — estradiol and progesterone — rather than synthetic alternatives. It is the form of HRT most widely prescribed by menopause specialists today. Available to women across New York's humid continental climate — entirely online.

Start Your Free Intake →

Licensed in New York · FDA-registered pharmacy · Reviewed within 24 hours · Ships free

Is Bioidentical HRT right for women in New York?

Connect with a kindr-licensed provider who can evaluate whether Bioidentical HRT is appropriate for your health history and symptoms — from anywhere in New York.

  • Full spectrum menopause symptoms
  • Sensitivity to synthetic hormones
  • Seeking personalized HRT dosing
  • Brain fog, mood, and sleep issues
  • Hot flashes and night sweats

What is bioidentical hrt?

Bioidentical hormone therapy uses estradiol and progesterone that are chemically identical to the hormones your ovaries produced before menopause. This is a molecular definition — not a regulatory or marketing category. Many FDA-approved products (estradiol patches, gels, and oral micronized progesterone) are bioidentical, as are compounded preparations from 503A pharmacies.

The distinction that matters clinically is between bioidentical hormones (estradiol, progesterone) and synthetic analogs (conjugated equine estrogens, medroxyprogesterone acetate). Bioidentical formulations have a different receptor-binding and metabolic profile and are the current first-line choice in menopause specialty practice.

How bioidentical hrt works

Bioidentical estradiol binds estrogen receptors alpha and beta with the same affinity as endogenous estradiol, restoring physiologic signaling in the brain, bone, cardiovascular system, and urogenital tissue. Micronized progesterone activates the progesterone receptor identically to ovarian progesterone and, through its metabolite allopregnanolone, exerts calming effects on the central nervous system via GABA-A receptors.

Because the molecules are identical to what the body already recognizes, they are metabolized through the same pathways as endogenous hormones, without the estrogenic and androgenic metabolites produced by some synthetic progestins.

The clinical evidence

The 2022 NAMS Position Statement, the Endocrine Society clinical practice guideline (Stuenkel et al., 2015), and the International Menopause Society Global Consensus all recognize bioidentical estradiol and micronized progesterone as evidence-based, first-line hormone therapy for symptomatic women within 10 years of menopause onset or under age 60.

The KEEPS and ELITE randomized trials used bioidentical transdermal estradiol and micronized progesterone and reported favorable cardiovascular and cognitive outcomes when treatment was initiated in this early-menopause window. The E3N cohort found a substantially better breast-cancer risk profile with estradiol plus micronized progesterone than with synthetic combinations.

Who is a good candidate?

  • Women in perimenopause or menopause with moderate to severe symptoms
  • Women within 10 years of their last menstrual period, or under age 60
  • Women who did not tolerate synthetic hormones or oral estrogen
  • Women seeking personalized doses rather than a small number of commercial strengths
  • Women prioritizing an evidence-based, up-to-date menopause care model

Contraindications

  • Personal history of estrogen-sensitive breast cancer or endometrial cancer
  • Active or recent venous thromboembolism, stroke, or coronary event
  • Undiagnosed abnormal uterine bleeding
  • Active liver disease
  • Known or suspected pregnancy

Common side effects

Most side effects are mild and settle within the first 4-8 weeks. Report anything severe or persistent to your prescriber.

  • Breast tenderness in the first 4-8 weeks
  • Mild fluid retention
  • Breakthrough bleeding in the first 3-6 months
  • Nighttime sedation from progesterone (usually desirable)
  • Mood changes during dose stabilization

Alternatives to consider

Synthetic HRT
Older regimens; still appropriate for some patients
Non-hormonal medications
Paroxetine or desvenlafaxine when hormones are contraindicated
Vaginal estrogen only
When symptoms are limited to urogenital tissue

Sources

  1. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
  2. Stuenkel CA et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011.
  3. Baber RJ et al. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109-150.
  4. Fournier A et al. Unequal risks for breast cancer associated with different hormone replacement therapies. Breast Cancer Res Treat. 2008;107(1):103-111.
  5. Hodis HN et al. Vascular effects of early versus late postmenopausal treatment with estradiol: ELITE trial. N Engl J Med. 2016;374:1221-1231.

Medically reviewed by the kindr Clinical Team. Content reflects the 2022 NAMS Position Statement and current Endocrine Society guidelines. Last reviewed 2026.

How kindr delivers care in New York

Step 1

Complete your intake online from anywhere in New York

Step 2

A licensed New York provider reviews within 24 hours

Step 3

If prescribed, ships free to your door

A kindr physician evaluates your symptoms and health history. Bioidentical estradiol and progesterone are prescribed in the exact formulations and doses your body needs — compounded by FDA-registered pharmacies.

What to expect

  • Weeks 1-2
    Sleep and night sweats improve
  • Weeks 4-6
    Hot flash frequency substantially reduced
  • Weeks 8-12
    Mood, energy, and cognitive symptoms stabilize
  • Months 6-12
    Full protocol effect; bone and urogenital benefits established

In 2025, the FDA updated its guidance on hormone therapy for menopause, removing longstanding warnings that had deterred many women from effective treatment. Speak with a kindr provider about what this means for you.

Clinical standards in New York

Board-certified MDs and DOs licensed in New York
FDA-registered 503A pharmacy fulfillment
HIPAA compliant and SOC 2 certified
Telehealth permitted under state law

New York frequently asked questions

Bioidentical HRT in nearby states

New JerseyMassachusettsPennsylvania

Ready to speak with a New York-licensed provider?

Connect with a board-certified kindr physician licensed to practice in New York. No waiting rooms. No referrals. Reviewed within 24 hours.

Start Your Free Intake →

Bioidentical HRT is a prescription medication. A licensed provider must evaluate whether this treatment is right for you. kindr is not a pharmacy. Medications are prescribed by licensed independent physicians and fulfilled by FDA-registered 503A compounding pharmacies. kindr does not guarantee any specific treatment will be prescribed.

Ask Dot